The Two Most Popular Healing Peptides
BPC-157 and TB-500 are the two most commonly used peptides for injury recovery, tissue repair, and healing. They’re often mentioned together — and frequently stacked — but they work through fundamentally different mechanisms. Understanding the differences helps you choose the right one for your injury.
The Master Comparison
| Feature | BPC-157 | TB-500 |
|---|---|---|
| Full name | Body Protection Compound-157 | Thymosin Beta-4 (synthetic fragment) |
| Origin | Synthetic, derived from human gastric juice protein | Synthetic, based on human thymosin beta-4 |
| Amino acids | 15 (pentadecapeptide) | 43 (full-length TB-4 fragment) |
| Primary mechanism | Angiogenesis + GH receptor upregulation | Cell migration + actin polymerization |
| Healing approach | Local tissue repair from within | Systemic healing support and cell mobilization |
| Best for | Tendons, ligaments, gut, localized injuries | Muscle, systemic inflammation, chronic injuries |
| Route | Subcutaneous (or oral for gut) | Subcutaneous |
| Dose | 250–500 mcg/day | 2.0–2.5 mg twice weekly |
| Dose units | Micrograms (mcg) | Milligrams (mg) |
| Cycle length | 4–8 weeks | 4–8 weeks |
| Onset | 1–3 weeks (pain reduction) | 2–4 weeks (gradual) |
| Oral viable? | Yes (gastric acid stable) | No |
| Cost/month | $40–80 | $80–150 |
| Published studies | Extensive (animal, some human) | Moderate (animal, limited human) |
| FDA status | Not approved (Category 2) | Not approved |
| WADA status | Banned (2022) | Banned |
How They Work — The Key Difference
BPC-157: The Local Healer
BPC-157 is a “build it here” peptide. Its primary effect is creating the conditions for local tissue repair:
- Angiogenesis — forms new blood vessels at the injury site via VEGFR2 upregulation, delivering more oxygen and nutrients to damaged tissue
- GH receptor upregulation — increases growth hormone receptor expression in tendon fibroblasts by up to 7-fold, making local tissue more responsive to circulating growth hormone
- Nitric oxide modulation — activates the Akt-eNOS pathway, improving blood flow to the injury
- Anti-inflammatory signaling — reduces pro-inflammatory cytokines at the injury site
- Cellular migration — activates FAK-paxillin and ERK1/2 pathways, promoting cell adhesion and survival at the repair site
Key insight: BPC-157 works primarily by improving the local repair environment. It makes the injury site a better place for healing to occur.
TB-500: The Systemic Mobilizer
TB-500 is a “send help everywhere” peptide. Its primary effect is mobilizing the body’s repair resources:
- Actin polymerization — TB-500 sequesters G-actin (monomeric actin), promoting new actin filament formation. This is essential for cell migration, wound closure, and tissue remodeling
- Cell migration promotion — activates stem cells and progenitor cells to migrate to injury sites throughout the body
- Anti-inflammatory effects — reduces systemic inflammation, including IL-1β and TNF-α
- Blood cell formation — promotes differentiation of blood vessel endothelial cells, supporting new vasculature
- Hair follicle stem cell activation — TB-500 has been shown to activate hair follicle stem cells (incidental to its cell migration mechanism)
Key insight: TB-500 works by mobilizing repair cells and resources systemically. It helps the body’s repair machinery find and reach damaged tissue.
Choosing Between Them
Decision Framework
Choose BPC-157 when:
- Injury is localized (specific tendon, ligament, joint)
- Gut issues (IBS, leaky gut, ulcers) — oral BPC-157 is uniquely effective
- Budget is a concern (BPC-157 is ~50% cheaper)
- You want the simpler protocol (daily injection vs twice-weekly)
- This is your first peptide (BPC-157 is the standard beginner healing peptide)
- Injury is acute (recent, within last few weeks)
Choose TB-500 when:
- Multiple injury sites or systemic inflammation
- Muscle-specific injuries (TB-500’s actin mechanism is particularly relevant to muscle tissue)
- Chronic, slow-healing injuries that haven’t responded to other treatments
- Post-surgical recovery (systemic mobilization of repair cells)
- You’re also interested in the hair growth side benefit
Stack both (Wolverine Stack) when:
- Severe injuries requiring maximum healing support
- Professional athletes or competitive users needing fastest possible return
- Chronic injuries that haven’t responded to either alone
- Post-surgical recovery from significant procedures
- Budget isn’t the primary constraint
By Injury Type
| Injury Type | Recommended | Why |
|---|---|---|
| Tendon injury (Achilles, patellar, rotator cuff) | BPC-157 (or stack) | GHR upregulation in tendon fibroblasts is BPC-157’s strongest mechanism |
| Ligament injury (ACL, MCL, ankle) | BPC-157 (or stack) | Angiogenesis and local repair excel for ligament tissue |
| Muscle strain/tear | TB-500 (or stack) | Actin polymerization and cell migration are critical for muscle regeneration |
| Gut issues (IBS, leaky gut, NSAID damage) | BPC-157 (oral) | BPC-157 is gastric acid stable; TB-500 has no oral route |
| Post-surgical recovery | Stack both | Surgery creates both local and systemic repair demands |
| Chronic inflammation | TB-500 | Systemic anti-inflammatory effects address diffuse inflammation |
| Bone fracture | Stack both | Both promote factors relevant to bone healing; limited direct evidence |
| Nerve injury | BPC-157 | Demonstrated nerve repair in published studies (sciatic, trigeminal) |
| Multiple simultaneous injuries | TB-500 (or stack) | Systemic mobilization reaches all sites simultaneously |
The Wolverine Stack
The BPC-157 + TB-500 combination is called the “Wolverine Stack” because the synergy between local repair (BPC-157) and systemic mobilization (TB-500) produces healing outcomes greater than either alone.
Standard Wolverine Stack Protocol
| Component | Dose | Frequency | Duration |
|---|---|---|---|
| BPC-157 | 250–500 mcg | Daily (SC injection) | 6–8 weeks |
| TB-500 | 2.0–2.5 mg | Twice weekly (SC injection) | 6–8 weeks |
Loading + Maintenance Approach
Some protocols front-load TB-500 for faster initial response:
| Phase | BPC-157 | TB-500 | Duration |
|---|---|---|---|
| Loading | 500 mcg daily | 2.5 mg 2x/week | Weeks 1–4 |
| Maintenance | 250 mcg daily | 2.0 mg 2x/week | Weeks 5–8 |
Cost Breakdown
| Component | Monthly Cost | 8-Week Cycle Cost |
|---|---|---|
| BPC-157 (500 mcg/day) | $60–80 | $120–160 |
| TB-500 (2.5 mg 2x/wk) | $80–120 | $160–240 |
| Wolverine Stack total | $140–200 | $280–400 |
Includes peptides only. Add ~$20 for BAC water and syringes.
Side Effect Comparison
Common Side Effects
| Side Effect | BPC-157 | TB-500 |
|---|---|---|
| Injection-site redness | Common | Common |
| Injection-site bruising | Occasional | Occasional |
| Mild headache | Rare | Rare |
| Nausea | Rare | Very rare |
| Fatigue | Very rare | Rare |
| Dizziness | Very rare | Very rare |
Safety Considerations
Both peptides share the same theoretical concern:
Angiogenesis and cancer. Both BPC-157 and TB-500 promote new blood vessel formation. While this is beneficial for healing, it could theoretically support tumor growth by providing blood supply to existing tumors. Neither peptide has been shown to cause cancer, but both are contraindicated in anyone with active malignancy, tumor history, or significant cancer risk factors.
Regulatory status. BPC-157 was classified as Category 2 by the FDA in September 2023, banning it from US compounding pharmacies. Both are banned by WADA (2022). Both remain available as research chemicals.
Research Quality Comparison
| Metric | BPC-157 | TB-500 |
|---|---|---|
| Total published studies | 100+ | 30+ |
| Human clinical trials | Very limited | Very limited |
| Animal study quality | Strong (consistent positive results) | Moderate |
| Systematic reviews | Yes (2019, Cell and Tissue Research) | Limited |
| Mechanism clarity | Well-characterized | Well-characterized |
| Safety data depth | Strong | Moderate |
| Community experience | Extensive (most popular healing peptide) | Significant |
The evidence gap: Both peptides suffer from the same fundamental limitation — extensive animal data but very limited human clinical trials. The community experience base is large and overwhelmingly positive, but this is anecdotal evidence, not controlled trial data.
Related Protocols
- BPC-157 Protocol — full dosing, injection, and cycle guide
- TB-500 Protocol — full dosing and systemic healing guide
- Wolverine Stack — the complete BPC-157 + TB-500 combination protocol
- Peptide Safety Guide — storage, injection technique, contraindications
- How to Inject Peptides — step-by-step injection guide
- Reconstitution Calculator — exact dosing math for both peptides
Frequently Asked Questions
Is BPC-157 or TB-500 better for tendon injuries? +
BPC-157 is generally preferred for tendon injuries. It directly upregulates growth hormone receptors in tendon fibroblasts (up to 7x) and promotes angiogenesis at the injury site. TB-500 provides systemic healing support but doesn't target tendon tissue as specifically. For severe tendon injuries, stacking both (the Wolverine Stack) provides the best coverage — BPC-157 for local repair and TB-500 for systemic support.
Can I take BPC-157 and TB-500 at the same time? +
Yes. The Wolverine Stack (BPC-157 + TB-500) is the most popular peptide combination for injury recovery. They work through complementary mechanisms — BPC-157 handles local tissue repair while TB-500 provides systemic healing and cell migration. Typical protocol: BPC-157 250–500 mcg daily + TB-500 2.0–2.5 mg twice weekly for 6–8 weeks.
Which is safer, BPC-157 or TB-500? +
Both have excellent safety profiles in published research. BPC-157 has more published studies and a longer track record, with no reported adverse events in any published study. TB-500 also shows a clean safety profile but with less published data. Neither is FDA-approved. Both promote angiogenesis, so both carry the same theoretical concern regarding active cancer.
Which is cheaper, BPC-157 or TB-500? +
BPC-157 is significantly cheaper per cycle. At standard dosing, BPC-157 costs approximately $40–80/month. TB-500 costs $80–150/month due to its higher per-dose requirements (milligrams vs micrograms). The Wolverine Stack (both together) runs approximately $120–200/month.
Do BPC-157 and TB-500 work for muscle injuries? +
Yes, both are effective for muscle injuries. BPC-157 accelerates muscle fiber repair and reduces inflammation at the injury site. TB-500 promotes satellite cell activation and migration to damaged muscle tissue, supporting muscle regeneration. For muscle strains, tears, and post-surgical muscle repair, either peptide alone is effective — stacking both provides faster, more complete recovery.